PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.59%
Revenue growth below 50% of VET's 10.80%. Michael Burry would check for competitive disadvantage risks.
-1.14%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
7.03%
Gross profit growth below 50% of VET's 14.85%. Michael Burry would check for structural issues.
2.33%
Margin expansion 50-75% of VET's 3.66%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
G&A reduction while VET shows 36.45% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
21.15%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
26.54%
Operating expenses growth above 1.5x VET's 13.80%. Michael Burry would check for inefficiency.
14.60%
Total costs growth above 1.5x VET's 7.45%. Michael Burry would check for inefficiency.
18.45%
Interest expense growth while VET reduces costs. John Neff would investigate differences.
1.03%
D&A growth less than half of VET's 7.24%. David Dodd would verify if efficiency is sustainable.
-50.89%
EBITDA decline while VET shows 12.54% growth. Joel Greenblatt would examine position.
-11.64%
EBITDA margin decline while VET shows 1.58% growth. Joel Greenblatt would examine position.
-152.91%
Operating income decline while VET shows 15.74% growth. Joel Greenblatt would examine position.
-150.59%
Operating margin decline while VET shows 4.47% growth. Joel Greenblatt would examine position.
-202.97%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-304.37%
Both companies show declining income. Martin Whitman would check industry conditions.
-295.40%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-303.49%
Both companies reducing tax expense. Martin Whitman would check patterns.
-305.00%
Both companies show declining income. Martin Whitman would check industry conditions.
-296.00%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-306.17%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-306.17%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-0.18%
Diluted share reduction while VET shows 7.07% change. Joel Greenblatt would examine strategy.